In This Section

Home / Advocate / Access, Payment & Reimbursement Reform

Access, Payment & Reimbursement Reform

ACCC is committed to ensuring that cancer patients have access to the entire continuum of quality cancer care, including access to the most appropriate cancer therapies.

  • ACCC Submits Letters to CMS on PFS and OPPS Regulations
    September 15, 2023

    On September 11, 2023, ACCC submitted comment letters to the Centers for Medicare and Medicaid Services (CMS) on the proposed physician fee schedule (PFS) and hospital outpatient prospective payment system (OPPS) regulations. Among other topics, ACCC supported the proposal for Medicare reimbursement for principal illness navigation (PIN) services to assist those with serious illnesses such as cancer.
    Read the First Letter Read the Second Letter

Final Medicare PFS and and HOPPS Rules and Policy Update

On Tuesday, December 12, 2023, ACCC hosted a virtual Oncology Reimbursement Meeting during which Teri Bedard, RT (R)(T), CPC and Nicole Tapay, JD discussed the final Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System rules.Download the full presentation.

ACCC Shares Resources to Address National Anti-Cancer Drug Shortages

National shortages of anti-cancer drugs, including cisplatin, carboplatin, and methotrexate, reached an all-time high during the first quarter of 2023. The Association of Cancer Care Centers (ACCC) recognizes the significant stress and concern caused by the scarcity of life-saving drugs for cancer patients nation-wide.

Dive in to learn about the advocacy efforts ACCC has championed to help patients and providers navigate cancer care under the current conditions.


Issues related to the oncology drug shortage prompted seven oncology care experts to gather for a roundtable discussion, Critical Conversation: National Drug Shortages and Empowering Oncology Pharmacists. ACCC has shared a recording and a transcript of their conversation.
Download the Q&A Transcript

From the ACCCBuzz Blog

  • Discussions that Matter: Managing Drug Shortages and Empowering Oncology Pharmacists
    July 18, 2023
    In the face of an unprecedented drug shortage, HOPA partnered with ACCC and AVAHO to lead a virtual round table discussing best practices the multidisciplinary cancer care team can use to mitigate its effects.
  • Discussions that Matter: A Look at the Current Drug Shortage
    July 10, 2023
    In the face of an unprecedented drug shortage, Hematology/Oncology Pharmacy Association (HOPA) partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table aimed at developing practical strategies healthcare organizations around the country can adopt.

Our Partners

hopa-200x80Association of VA Hematology/Oncology (AVAHO).

In partnership with Hematology/Oncology Pharmacy Association (HOPA) and Association of VA Hematology/Oncology (AVAHO).

Enhancing Oncology Model (EOM) Resources

  • The Innovation Center Releases EOM Factsheets

    Last year, the Center for Medicare & Medicaid Innovation (the Innovation Center) announced the  Enhancing Oncology Model (EOM)—the Oncology Care Model's successor. Now, the Innovation Center has released two resources to help EOM stakeholders understand the model's health equity strategy and new enhanced services requirement. 

    The application period for the EOM closed on October 10, 2022, and the Centers for Medicare & Medicaid Services is in the process of reviewing submitted applications in advance of the model launch on July 1, 2023.

    For more information on the EOM, visit its dedicated its dedicated website, email its support team, or call 1.888.734.6433, option 3.


  • CMS Delays Radiation Oncology Model For Further Rulemaking

    On August 29, 2022, the Centers for Medicare & Medicaid Services (CMS) published a final rule (CMS-5527-F2) that finalized delaying the Radiation Oncology Model start date until a date is determined through future rulemaking.

    For more information, visit the Radiation Oncology Model website.

    Posted 8/30/2022

  • CMS Announces the Enhancing Oncology Model

    On June 27, 2022, the Biden Administration, through the Department of Health and Human Services and Centers for Medicare & Medicaid Services (CMS), announced a new model to improve cancer care for Medicare patients: the Enhancing Oncology Model (EOM). This model is the successor to the Oncology Care Model (OCM).

    The EOM—designed by the Center for Medicare and Medicaid Innovation—will tackle the health inequities and meet patients' throughout the cancer care continuum, with an emphasis on person-centered care and better patient outcomes. The model will run from July 2023 through June 2028, and its participants will include oncology practices that treat people with Medicare undergoing chemotherapy for breast cancer, chronic leukemia, lung cancer, lymphoma, multiple myeloma, prostate cancer, and small intestine/colorectal cancer. 

    For additional information regarding the EOM, visit the CMS website. Then read ACCC's statement.

    Posted 6/29/2022

Archived Documents

Archive of ACCC Comment Letters on CMS Physician Fee Schedule:

Archive of ACCC Comment Letters to CMS on Recent OPPS Proposed Rules: